Clinician-patient discord: Exploring differences in perspectives for discontinuing clopidogrel

European Journal of Cardiovascular Nursing

Volumn 10, Issue 1, 2011, Pages 50-55

  Garavalia, Linda ^a   Ho, P Michael ^b   Garavalia, Brian ^c   Foody, JoAnne M ^d   Kruse, Heather ^a   Spertus, John A ^c,e   Decker, Carole ^a,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Medication discontinuance; Myocardial infarction; Patient provider communication; Qualitative research

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG ELUTING STENT; EDUCATIONAL STATUS; FEMALE; HEALTH CARE COST; HEART INFARCTION; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; NURSE PRACTITIONER; PRIORITY JOURNAL; TREATMENT DURATION; UNITED STATES;

AGED; ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; COMMUNICATION; COMORBIDITY; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENTS; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; PLATELET AGGREGATION INHIBITORS; QUALITATIVE RESEARCH; THROMBOSIS; TICLOPIDINE;

EID: 77957258130     PISSN: 14745151     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcnurse.2010.04.002     Document Type: Article

References (29)

1. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006, 113:2363-2372.
2. Bavry A.A., Kumbhani D.J., Helton T.J., Borek P.P., Mood G.R., Bhatt D.L. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006, 119:1056-1061.
3. Eisenstein E.L., Anstrom K.J., Kong D.F., Shaw L.K., Tuttle R.H., Mark D.B., et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007, 297:159-168.
4. Kaul S., Shah P.K., Diamond G.A. As time goes by: current status and future directions in the controversy over stenting. J Am Colloid Cardiol 2007, 50:128-137.
5. Grines C.L., Bonow R.O., Casey D.E., Gardner T.J., Lockhart P.B., Moliterno D.J., et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007, 115:813-818.
6. Thomas D., Giugliano R.P. Management of ST-segment elevation myocardial infarction: comparison of the updated guidelines from North America and Europe. Am Heart J 2009, 158:695-705.
7. Spertus J.A., Kettelkamp R., Vance C., Decker C., Jones P.G., Rumsfeld J.S., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 2006, 113:2803-2809.
8. DiMatteo M.R., Giordani P.J., Lepper H.S., Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care 2002, 40:794-811.
9. Sud A., Kline-Rogers E.M., Eagle K.A., Fang J., Armstrong D.F., Rangarajan K., et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother 2005, 39:1792-1797.
10. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
11. Coleman E.A., Smith J.D., Raha D., Min S.J. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med 2005, 165:1842-1847.
12. Iakovou I., Colombo A. A thrombosis after implantation of drug-eluting stents-reply. JAMA 2006, 295:36.
13. Decker C., Garavalia L., Garavalia B., Spertus J.A. Clopidogrel taking behavior by drug eluting stent patients: discontinuers versus continuers. Patient Prefer Adherence 2008, 2:167-175.
14. Devereaux P.J., Anderson D.R., Gardner M.J., Putnam W., Flowerdew G.J., Brownell B.F., et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. BMJ 2001, 323:1218-1222.
15. Morris L.S., Schulz R.M. Patient compliance-an overview. J Clin Pharm Ther 1992, 17:283-295.
16. Bhatt D.L., Topol E.J. Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J 2004, 148:263-268.
17. Lewis B.S., Mehta S.R., Fox K.A., Halon D.A., Zhao F., Peters R.J., et al. Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. Am Heart J 2005, 150:1177-1184.
18. Stimson G.V. Obeying doctor's orders: a view from the other side. Soc Sci Med 1974, 8:97-104.
19. Bebbington P.E. The content and context of compliance. Int Clin Psychopharmacol 1995, 9(Suppl 5):41-50.
20. George J., Kong D.C., Thoman R., Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005, 128:3198-3204.
21. Becker M.H. The health belief model and sick role behavior. Health Educ Monogr 1974, 2:409-419.
22. Janz N.K., Becker M.H. The Health Belief Model: a decade later. Health Educ Q 1984, 11:1-47.
23. Rosenstock I.M. Why people use health services. Milbank Meml Fund Q 1966, 44:94-127. Suppl.
24. Marshall M.N. Sampling for qualitative research. Fam Pract 1996, 13:522-525.
25. Elo S., Kyngas H. The qualitative content analysis process. J Adv Nurs 2008, 62:107-115.
26. Makaryus A.N., Friedman E.A. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc 2005, 80:991-994.
27. Tarn D.M., Heritage J., Paterniti D.A., Hays R.D., Kravitz R.L., Wenger N.S. Physician communication when prescribing new medications. Arch Intern Med 2006, 166:1855-1862.
28. Kripalani S., LeFevre F., Phillips C.O., Williams M.V., Basaviah P., Baker D.W. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA 2007, 297:831-841.
29. Lehane E., McCarthy G., Collender V., Deasy A. Medication-taking for coronary artery disease - patients' perspectives. Eur J Cardiovasc Nurs 2008, 7:133-139.